Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial

By sjmartinez • February 15, 2023

Carson JL, Brooks MM, Chaitman BR, Alexander JH, Goodman SG, Bertolet M, Abbott JD, Cooper HA, Rao SV, Triulzi DJ, Fergusson DA, Kostis WJ, Noveck H, Simon T, Steg PG, DeFilippis AP, Goldsweig AM, Lopes RD, White H, Alsweiler C, Morton E, Hébert PC; MINT Investigators. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial. Am Heart J. 2023 Mar;257:120-129. doi: 10.1016/j.ahj.2022.11.015. Epub 2022 Nov 20. PMID: 36417955; PMCID: PMC9928777.

Tags: Cardiology/Epi, Publications, Veterans Administration

Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors along with colchicine versus colchicine alone among coronary artery disease and type 2 diabetes patients

Jaiswal V, Hanif M, Kumar D, Mashkoor Y, Kumar T, Ahmed R, Mattumpuram J, Qamar A, Fonarow GC, Lavie CJ. Comparative effectiveness of sodium-glucose cotransporter[...]

Transgenic mice overexpressing Pitx2 in the atria develop tachycardia-bradycardia syndrome

Baba S, Shinjo S, Seya D, Bochimoto H, Akaike T, Nakano A, Minamisawa S. Transgenic mice overexpressing Pitx2 in the atria develop tachycardia-bradycardia syndrome. PLoS[...]

Predicting risk of cardiovascular events (PREVENT) score accuracy among people with HIV in the multicenter CNICS cohort

Durstenfeld MS, Nance RM, Jones R, Abelman R, Hoffmann AP, Burkholder G, Hsue PY, Longenecker CT, Hunt PW, Saag MS, Delaney JAC, Feinstein MJ, Crane[...]